Pluristem Therapeutics Inc PSTI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:53 AM EDT
1.55quote price arrow down-0.03 (-1.90%)
Volume
5,132
52 week range
1.31 - 4.55
Loading...
  • Open1.55
  • Day High1.57
  • Day Low1.55
  • Prev Close1.58
  • 52 Week High4.55
  • 52 Week High Date06/11/21
  • 52 Week Low1.31
  • 52 Week Low Date05/16/22

Key Stats

  • Market Cap50.14M
  • Shares Out32.35M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.94
  • YTD % Change7.19

KEY STATS

  • Open1.55
  • Day High1.57
  • Day Low1.55
  • Prev Close1.58
  • 52 Week High4.55
  • 52 Week High Date06/11/21
  • 52 Week Low1.31
  • 52 Week Low Date05/16/22
  • Market Cap50.14M
  • Shares Out32.35M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta1.94
  • YTD % Change7.19

RATIOS/PROFITABILITY

  • EPS (TTM)-1.47
  • P/E (TTM)-1.06
  • Fwd P/E (NTM)-0.99
  • EBITDA (TTM)-46.047M
  • ROE (TTM)-88.22%
  • Revenue (TTM)230,000.00
  • Gross Margin (TTM)0.00%
  • Net Margin (TTM)-20,024.79%
  • Debt To Equity (MRQ)60.18%

EVENTS

  • Earnings Date09/12/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pluristem Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Pluristem Therapeutics Inc. is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Company's lead indications are critical limb ischemia (CLI), recovery after surgery for femoral neck fracture and acute radiation syndrome. Its operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. The Company's products...
Zalman Aberman
Executive Chairman of the Board
Yaky Yanay
President, Chief Executive Officer, Director
Chen Franco-Yehuda
Chief Financial Officer, Treasurer, Secretary
Address
Matam Advanced Technology Park
Building No. 5
Haifa
3508409
Israel

Top Peers

SYMBOLLASTCHG%CHG
CRVS
Corvus Pharmaceuticals Inc
1.02-0.03-2.86%
SNSE
Sensei Biotherapeutics Inc
1.73+0.03+1.76%
RPHM
Reneo Pharmaceuticals Inc
2.10-0.02-0.94%
RZLT
Rezolute Inc
2.95-0.05-1.67%
AIM
AIM ImmunoTech Inc
0.9195-0.0005-0.0543%